Regulation of Cellular Activation (B)
Signal Transduction through Interferon–Gamma Receptor on Human EosinophilsOchiai K.a · Ishihara C.b · Tomioka H.a
Departments of aInternal Medicine and bPediatrics, Toho University School of Medicine, Sakura Hospital, Sakura, Japan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background: We reported on the constitutive interferon–γ receptor (IFN–γR) expression on eosinophils. But signal transduction through IFN–γR on eosinophils remains to be elucidated. In this study, we examined the involvement of the Jak/Stat pathway in the signaling of eosinophils after IFN–γR conjugation by the ligand binding. Methods: Purified peripheral eosinophils were stimulated with IFN–γ at 37°C for 1–60 min. Tyrosine phosphorylation of IFN–γR, Jak1, Jak2, and Stat1α was examined by immunoblotting. Gel–shift assay was also examined to show the formation of Stat1α–DNA complexes. Results: We show that binding of IFN–γ to human eosinophils initiated a series of events that resulted in the rapid tyrosine phosphorylation of not only the IFN–γRα chain but also Jak1, Jak2, and Stat1α. In addition, IFN–γ enhanced the DNA–binding activity of Stat1α. Conclusion: These data indicate that IFN–γ affects eosinophils through its specific receptor and utilizes the Jak/Stat pathway as its mode of signaling.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.